FDA Approves First Naloxone Product for Over-the-Counter Use

The AMA, substance abuse experts share their thoughts on this decision and what it means for psychiatric clinicians and their patients.

Related Keywords

Toronto ,Ontario ,Canada ,Texas ,United States ,Baylor College Of Medicine ,Houston ,American ,Americans ,Bobby Mukkamala ,Patrizia Cavazzoni ,Tonyp George ,Thomasr Kosten ,Jayh Waggoner ,Us Food Drug Administration ,Institute For Clinical ,University Of Toronto ,Pain Care Task ,American Medical Association ,American College Of Neuropsychopharmacology ,Translational Research ,Drug Administration ,Drug Evaluation ,Pain Care Task Force ,Psychiatric Times ,Editorial Board ,American College ,Endowed Chair ,Baylor College ,